18 -glycyrrhetinic acid inhibits rotavirus replication in culture

Virology Journal

Volumn 9, Issue , 2012, Pages

  Hardy, Michele E ^a   Hendricks, Jay M ^a   Paulson, Jeana M ^a   Faunce, Nicholas R ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

18beta glycyrrhetinic acid; Antiviral; Licorice; Rotavirus

Indexed keywords

GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; NEOMINOPHAGEN C; PROTEIN VP2; PROTEIN VP6; 18ALPHA GLYCYRRHETINIC ACID; 18ALPHA-GLYCYRRHETINIC ACID; CAPSID PROTEIN; DRUG DERIVATIVE; NS35 PROTEIN, ROTAVIRUS; RNA BINDING PROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN; VP2 PROTEIN, ROTAVIRUS; VP6 PROTEIN, ROTAVIRUS;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; NONHUMAN; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS CULTURE; VIRUS REPLICATION; ANIMAL; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HAPLORHINI; METABOLISM; PHYSIOLOGY;

GLYCYRRHIZA; ROTAVIRUS;

ANIMALS; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; HAPLORHINI; RNA-BINDING PROTEINS; ROTAVIRUS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84861208535     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-96     Document Type: Article

References (40)

1. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U, J Infect Dis 2009 Suppl 1 1 S8
2. Safety and efficacy of a pentavalent human - bovine (WC3) reassortant rotavirus vaccine. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. N Engl J Med 2006 354 1 23 33 10.1056/NEJMoa052664 16394299 (Pubitemid 43048948)
3. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. N Engl J Med 2006 354 1 11 22 10.1056/NEJMoa052434 16394298 (Pubitemid 43048947)
4. Rotarix (R): vaccine performance 6 years postlicensure. O'Ryan M, Lucero Y, Linhares AC, Expert Rev Vaccines 2011 10 12 1645 1659 10.1586/erv.11.152 22085167
5. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq. Ciarlet M, Schodel F, Vaccine 2009 27 Suppl 6 72 G81 20006144
6. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double - blind, placebo - controlled trial. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al. Lancet 2010 376 9741 615 623 10.1016/S0140-6736(10)60755-6 20692031
7. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub - Saharan Africa: a randomised, double - blind, placebo - controlled trial. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Lancet 2010 376 606 614 10.1016/S0140-6736(10)60889-6 20692030
8. A history of the therapeutic use of liquorice in Europe. Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D, J Ethnopharmacol 2005 99 3 317 324 10.1016/j.jep.2005.04.015 15978760 (Pubitemid 40854146)
9. Robbers JSS MK, Tyler VE, Pharmacognosy and Pharmacobiotechnology Williams and Wilkins, Baltimore 1996
10. Barnes JA, Anderson LA, Phillipson JD, Herbal Medicine Pharmaceutical Press, London 2002
11. Metabolism of glycyrrhizin by human intestinal flora. Hattori M, Sakamoto T, Kobashi K, Namba T, Planta Med 1983 48 5 38 42 10.1055/s-2007-969875 6611743 (Pubitemid 13068054)
12. Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Hattori M, Sakamoto T, Yamagishi T, Sakamoto K, Konishi K, Kobashi K, Namba T, Chem Pharm Bull (Tokyo) 1985 33 1 210 217 10.1248/cpb.33.210 (Pubitemid 15130851)
13. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW, Aliment Pharmacol Ther 1998 12 3 199 205 10.1046/j.1365-2036.1998.00309.x 9570253 (Pubitemid 28160013)
14. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, Kullak-Ublick GA, Gerken G, Zeuzem S, Nevens F, Tielemans WC, et al. J Hepatol 2006 45 4 539 546 10.1016/j.jhep.2006.05.015 16905220 (Pubitemid 44316866)
15. A long - term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon - resistant active chronic hepatitis C: a cohort study of 1249 patients. Ikeda K, Arase Y, Kobayashi M, Saitoh S, Someya T, Hosaka T, Sezaki H, Akuta N, Suzuki Y, Suzuki F, et al. Dig Dis Sci 2006 51 3 603 609 10.1007/s10620-006-3177-0 16614974
16. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H, Cancer 1997 79 8 1494 1500 10.1002/(SICI)1097- 0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B 9118029 (Pubitemid 27154778)
17. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F, Antimicrob Agents Chemother 1997 41 3 551 556 9055991 (Pubitemid 27098402)
18. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Pompei R, Flore O, Marccialis MA, Pani A, Loddo B, Nature 1979 281 5733 689 690 10.1038/281689a0 233133 (Pubitemid 10249050)
19. Antiviral effects of Glycyrrhiza species. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, Bielenberg J, Phytother Res 2008 22 2 141 148 10.1002/ptr.2295 17886224 (Pubitemid 351363230)
20. Glycyrrhizin inhibits influenza A virus uptake into the cell. Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH, Antiviral Res 2009 83 2 171 178 10.1016/j.antiviral.2009.04.012 19416738
21. The broad anti - viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV - 1 envelope. Harada S, Biochem J 2005 392 Pt 1 191 199 16053446 (Pubitemid 41689415)
22. Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus - infected cells and inhibits virus replication and pro - inflammatory gene expression. Michaelis M, Geiler J, Naczk P, Sithisarn P, Leutz A, Doerr HW, Cinatl J, PLoS One 2011 6 5 19705 10.1371/journal.pone.0019705 21611183
23. History of the endocrine effects of licorice. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M, Experimental and Clinical Endocrinology and Diabetes 2002 110 257 261 10.1055/s-2002-34587 12373628 (Pubitemid 35246741)
24. Induction of inducible nitric oxide synthase expression by 18beta - glycyrrhetinic acid in macrophages. Jeong HG, Kim JY, FEBS Lett 2002 513 2-3 208 212 10.1016/S0014-5793(02)02311-6 11904152 (Pubitemid 34251266)
25. Natural products that reduce rotavirus infectivity identified by a cell - based moderate - throughput screening assay. Shaneyfelt ME, Burke AD, Graff JW, Jutila MA, Hardy ME, Virol J 2006 3 68 10.1186/1743-422X-3-68 16948846 (Pubitemid 44401679)
26. Inhibition of interleukin - 8 production in the human colonic epithelial cell line HT - 29 by 18 beta - glycyrrhetinic acid. Kang OH, Kim JA, Choi YA, Park HJ, Kim DK, An YH, Choi SC, Yun KJ, Nah YH, Cai XF, et al. Int J Mol Med 2005 15 6 981 985 15870903
27. Glycyrrhizic acid and 18beta - glycyrrhetinic acid modulate lipopolysaccharide - induced inflammatory response by suppression of NF - kappaB through PI3K p110delta and p110gamma inhibitions. Wang CY, Kao TC, Lo WH, Yen GC, J Agric Food Chem 2011 59 14 7726 7733 10.1021/jf2013265 21644799
28. 18 Beta - glycyrrhetinic acid triggers curative Th1 response and nitric oxide up - regulation in experimental visceral leishmaniasis associated with the activation of NF - kappa B. Ukil A, Biswas A, Das T, Das PK, J Immunol 2005 175 2 1161 1169 16002718 (Pubitemid 41095003)
29. Glycyrrhetinic acid protects mice from Staphylococcus aureus pneumonia. Li HE, Qiu JZ, Yang ZQ, Dong J, Wang JF, Luo MJ, Pan J, Dai XH, Zhang Y, Song BL, et al. Fitoterapia 2012 83 1 241 248 10.1016/j.fitote.2011.10.018 22085765
30. Entry of rotaviruses is a multistep process. Mendez E, Lopez S, Cuadras MA, Romero P, Arias CF, Virology 1999 263 2 450 459 10.1006/viro.1999.9976 10544117 (Pubitemid 29521536)
31. Characterization of rotavirus cell entry. Sanchez-San Martin C, Lopez T, Arias CF, Lopez S, J Virol 2004 78 5 2310 2318 10.1128/JVI.78.5.2310-2318.2004 14963127 (Pubitemid 38228924)
32. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Asl MN, Hosseinzadeh H, Phytother Res 2008 22 6 709 724 10.1002/ptr.2362 18446848 (Pubitemid 351955567)
33. Antiviral properties of glycyrrhizic acid and its semisynthetic derivatives. Pompei R, Laconi S, Ingianni A, Mini Rev Med Chem 2009 9 8 996 1001 19601894
34. Kinetics and dynamics of orally administered 18 beta - glycyrrhetinic acid in humans. Krahenbuhl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R, J Clin Endocrinol Metab 1994 78 3 581 585 10.1210/jc.78.3.581 8126129 (Pubitemid 24083295)
35. Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome - dependent degradation of beta - TrCP: a novel mechanism of IFN antagonism. Graff JW, Ettayebi K, Hardy ME, PLoS Pathog 2009 5 1 1000280 10.1371/journal.ppat. 1000280 19180189
36. Glycyrrhetinic acid inhibits ICAM - 1 expression via blocking JNK and NF - kappaB pathways in TNF - alpha - activated endothelial cells. Chang YL, Chen CL, Kuo CL, Chen BC, You JS, Acta Pharmacol Sin 2010 31 5 546 553 10.1038/aps.2010.34 20418897
37. Glycyrrhizic acid and 18beta - glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. Kao TC, Shyu MH, Yen GC, J Agric Food Chem 2010 58 15 8623 8629 10.1021/jf101841r 20681651
38. Neuroprotective effects of glycyrrhizic acid and 18beta - glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway. Kao TC, Shyu MH, Yen GC, J Agric Food Chem 2009 57 2 754 761 10.1021/jf802864k 19105645
39. Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3 - kinase - dependent pathway, resulting in increased cell adhesion and virus yield. Halasz P, Holloway G, Turner SJ, Coulson BS, J Virol 2008 82 1 148 160 10.1128/JVI.01980-07 17942548 (Pubitemid 350309132)
40. Rotavirus infection activates the UPR but modulates its activity. Zambrano JL, Ettayebi K, Maaty WS, Faunce NR, Bothner B, Hardy ME, Virol J 2011 8 359 10.1186/1743-422X-8-359 21774819